School of Medicine
Showing 61-70 of 429 Results
-
Dawn Duane
Clinical Professor, Pediatric Neurology
Clinical Professor (By courtesy), PediatricsCurrent Research and Scholarly InterestsI am a general pediatric neurologist. My interest is in clinical diagnosis and treatment of common neurologic diseases in pediatric patients and teaching feature doctors, neurologists and pediatric neurologists about pediatric neurology.
-
Rachelle Dugue, MD, PhD
Clinical Assistant Professor, Adult Neurology
BioDr. Dugue is a board-certified neurologist within the Neurohospitalist Division. She cares for patients at both Stanford Health Care and Stanford Health Care Tri-Valley. She received her MD and PhD at SUNY Downstate Medical Center, where she completed a thesis studying novel treatments for traumatic brain injury. Dr. Dugue then completed her neurology residency at Columbia University Medical Center-New York Presbyterian, followed by a vascular neurology fellowship at Stanford University Hospital.
Dr. Dugue provides comprehensive, individualized care for patients with a wide range of neurological conditions. She has been recognized for her dedication to excellence in patient care, medical education, and student mentorship.
Her research interests are centered on acute neurologic care, clinical trials, stroke, and neuroinfectious disease. Dr. Dugue has published in multiple peer-reviewed journals, including The Neurohospitalist, Practical Neurology, Annals of Clinical and Translational Neurology, and Neurology. -
Shefali Dujari, MD
Clinical Associate Professor, Adult Neurology
BioDr. Dujari is a board-certified neurologist and fellowship-trained neurohospitalist, specializing in the care of acute neurologic disorders. She practices at both Stanford Hospital and Stanford ValleyCare. She completed her medical training at Boston University, internal medicine preliminary year at California Pacific Medical Center, neurology residency at Stanford University where she served as chief resident in her final year, and neurohospitalist fellowship at Stanford University. She joined the Stanford Neurohospitalist Program in 2021. Dr. Dujari serves as the Associate Program Director for the Stanford Adult Neurology Residency Program and Director of Quality for Neurosciences at Stanford Health Care - TriValley. She is currently the Vice President of the Neurohospitalist Society.
-
Jeffrey Dunn, MD
Clinical Professor, Adult Neurology
Current Research and Scholarly InterestsTranslational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.
-
Tina Duong MPT, PhD
Sr Res Scientist-Basic Life, Adult Neurology
BioAs the Director of Clinical Outcomes and Research Development, and the Co-Founder and Co-Director of the Neuro-IGNITE Center at the Stanford University School of Medicine, I focus on translational rehabilitation science, psychometric measurement theory, clinical outcomes development, trial design, and digital health technology for individuals with neuromuscular disorders.
My research is guided by a simple premise: measurement determines access. Individuals who are harder to measure, and constructs that are meaningful to patients but difficult to quantify, are frequently overlooked in clinical trials, limiting both trial participation and treatment access. Complementing established functional scales, our team works to bridge this gap by defining the concept of interest and context of use with patients, clinicians, and regulators, then developing and validating fit-for-purpose clinical outcome assessments and digital endpoints across neuromuscular disorders, including spinal muscular atrophy, Duchenne muscular dystrophy, myotonic dystrophy, and facioscapulohumeral muscular dystrophy. This alignment supports a clearer regulatory path so that patients who have been difficult to measure can qualify for trials, demonstrate meaningful benefit, and gain access to therapies.
Bridging clinical expertise and computational engineering, I collaborate with bioengineers to integrate digital health tools, including markerless motion capture (OpenCap) and multimodal sensors (wearables, video and imaging biomarkers, cardiopulmonary exercise testing) into clinical research. Together, we aim to better understand disease mechanisms and functional impact across the drug development pipeline. This work has contributed high-resolution, video-based kinematic datasets and minimal clinically important difference (MCID) thresholds that inform regulatory benchmarks for clinical trials and therapeutic evaluations.
Key Academic & Research Focus Areas:
•Outcome Measure Development & Psychometrics: Developing and validating functional instruments and digital biomarkers designed to meet regulatory standards in rare diseases.
•Digital Biomechanics & Kinematic Modeling: Applying markerless motion capture and wearable inertial sensors to quantify disease progression and subtle changes in movement.
•Translational Clinical Trial Design: Advising on endpoint selection and contributing to international natural history studies to improve trial readiness, reduce participant burden, and strengthen statistical sensitivity.
•Scientific Leadership & Mentorship: Leading multi-center academic consortia, publishing peer-reviewed research, and mentoring the next generation of clinical researchers.
